Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023

SELL
$18.01 - $23.78 $11,526 - $15,219
-640 Reduced 39.02%
1,000 $0
Q3 2022

Oct 26, 2022

BUY
$16.32 - $26.37 $16,825 - $27,187
1,031 Added 169.29%
1,640 $31,000
Q2 2022

Jul 25, 2022

BUY
$18.54 - $37.29 $8,139 - $16,370
439 Added 258.24%
609 $12,000
Q1 2022

May 02, 2022

BUY
$23.94 - $33.74 $4,069 - $5,735
170 New
170 $5,000

Others Institutions Holding ALBO

About ALBIREO PHARMA, INC.


  • Ticker ALBO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,612,500
  • Description
  • Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...
More about ALBO
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.